2-(4-cyclopropyl-6-methoxypyrimidin-5-yl)-9-({4-[1-methyl-4-(trifluoromethyl)-1H-imidazol-2-yl]phenyl}methyl)-7-(2,2,2-trifluoroethyl)-8,9-dihydro-7H-purin-8-imine
Structure Info
- Chemspace ID
- CSSB20465146705 (In-Stock Building Blocks)
- MFCD
- MFCD35444317
- IUPAC Name
- 2-(4-cyclopropyl-6-methoxypyrimidin-5-yl)-9-({4-[1-methyl-4-(trifluoromethyl)-1H-imidazol-2-yl]phenyl}methyl)-7-(2,2,2-trifluoroethyl)-8,9-dihydro-7H-purin-8-imine
- Mol formula
- C27H23F6N9O
- Mol weight
- 604 Da
- Catalog Number(s)
- 201658, A2692213, AA02EOH4, ACQRWL213, AG-B37703, AG02EOJW, BD02531057, BO44036, BUP24187, H84504, HY-160700, ST02EQ0O, T88075, TX02EPPK, Y5183758
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 6.23
- Heavy atoms count
- 43
- Rotatable bond count
- 9
- Number of rings
- 6
- Carbon bond saturation, Fsp3
- 0.333
- Polar surface area (Å)
- 109
- Hydrogen bond acceptors count
- 9
- Hydrogen bond donors count
- 1
- Zoom the structure
- CSSB20465146705
Items Overall 48 items from 10 suppliers
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| 1st Scientific CN | 7 days | China To: | 95 | 1 mg | 66.00 | |
| 1st Scientific CN | 7 days | China To: | 95 | 5 mg | 124.30 | |
| 1st Scientific CN | 7 days | China To: | 95 | 10 mg | 183.70 | |
| 1st Scientific CN | 7 days | China To: | 95 | 25 mg | 313.50 | |
| 1st Scientific CN | 7 days | China To: | 95 | 50 mg | 431.20 | |
| 1st Scientific CN | 7 days | China To: | 95 | 100 mg | 649.00 | |
Description: 2-(4-Cyclopropyl-6-methoxypyrimidin-5-yl)-9-(4-(1-methyl-4-(trifluoromethyl)-1H-imidazol-2-yl)benzyl)-7-(2,2,2-trifluoroethyl)-7,9-dihydro-8H-purin-8-imine; CAS: 2839740-79-1 | ||||||
| BLD PHARMATECH LTD CN | 7 days | China To: | 95 | 1 mg | 79.00 | |
| BLD PHARMATECH LTD CN | 7 days | China To: | 95 | 5 mg | 150.00 | |
| BLD PHARMATECH LTD CN | 7 days | China To: | 95 | 10 mg | 222.00 | |
| BLD PHARMATECH LTD CN | 7 days | China To: | 95 | 25 mg | 379.00 | |
| BLD PHARMATECH LTD CN | 7 days | China To: | 95 | 50 mg | 522.00 | |
| BLD PHARMATECH LTD CN | 7 days | China To: | 95 | 100 mg | 786.00 | |
| BLD PHARMATECH LTD CN | 7 days | China To: | 95 | 250 mg | 1,415.00 | |
Description: Name:2-(4-Cyclopropyl-6-methoxypyrimidin-5-yl)-9-(4-(1-methyl-4-(trifluoromethyl)-1H-imidazol-2-yl)benzyl)-7-(2,2,2-trifluoroethyl)-7,9-dihydro-8H-purin-8-imine; CAS: 2839740-79-1 | ||||||
| AiFChem CN | 10 days | China To: | 95 | 1 mg | 73.00 | |
| AiFChem CN | 10 days | China To: | 95 | 5 mg | 139.00 | |
| AiFChem CN | 10 days | China To: | 95 | 10 mg | 206.00 | |
| AiFChem CN | 10 days | China To: | 95 | 25 mg | 352.00 | |
| AiFChem CN | 10 days | China To: | 95 | 50 mg | 485.00 | |
| AiFChem CN | 10 days | China To: | 95 | 100 mg | 730.00 | |
Description: 2-(4-Cyclopropyl-6-methoxypyrimidin-5-yl)-9-(4-(1-methyl-4-(trifluoromethyl)-1H-imidazol-2-yl)benzyl)-7-(2,2,2-trifluoroethyl)-7,9-dihydro-8H-purin-8-imine; Hazard statement: H302, H315, H319; CAS: 2839740-79-1 | ||||||
| Angel Pharmatech Ltd. | 10 days | China To: | 97 | 10 mg | 560.00 | |
| Angel Pharmatech Ltd. | 10 days | China To: | 97 | 25 mg | 1,050.00 | |
| Angel Pharmatech Ltd. | 10 days | China To: | 97 | 50 mg | 1,680.00 | |
| Angel Pharmatech Ltd. | 10 days | China To: | 97 | 100 mg | 2,680.00 | |
Description: CAS: 2839740-79-1 | ||||||
| Ambeed CN | 12 days | China To: | 95 | 1 mg | 71.10 | |
| Ambeed CN | 12 days | China To: | 95 | 5 mg | 135.00 | |
| Ambeed CN | 12 days | China To: | 95 | 10 mg | 199.80 | |
| Ambeed CN | 12 days | China To: | 95 | 25 mg | 341.10 | |
| Ambeed CN | 12 days | China To: | 95 | 50 mg | 469.80 | |
| Ambeed CN | 12 days | China To: | 95 | 100 mg | 707.40 | |
| Ambeed CN | 12 days | China To: | 95 | 250 mg | 1,273.50 | |
Description: Name: TNG348; CAS: 2839740-79-1 | ||||||
| Ambeed, Inc. | 12 days | United States To: | 95 | 1 mg | 71.10 | |
Description: Name: TNG348; CAS: 2839740-79-1 | ||||||
| AA BLOCKS | 12 days | United States To: | 95 | 1 mg | 77.00 | |
Description: 2-(4-Cyclopropyl-6-methoxypyrimidin-5-yl)-9-(4-(1-methyl-4-(trifluoromethyl)-1H-imidazol-2-yl)benzyl)-7-(2,2,2-trifluoroethyl)-7,9-dihydro-8H-purin-8-imine; CAS: 2839740-79-1 | ||||||
| A2B Chem | 12 days | United States To: | 95 | 1 mg | 90.85 | |
| A2B Chem | 12 days | United States To: | 95 | 5 mg | 172.50 | |
| A2B Chem | 12 days | United States To: | 95 | 10 mg | 255.30 | |
| A2B Chem | 12 days | United States To: | 95 | 25 mg | 435.85 | |
| A2B Chem | 12 days | United States To: | 95 | 50 mg | 600.30 | |
| A2B Chem | 12 days | United States To: | 95 | 100 mg | 903.90 | |
Description: 2-(4-Cyclopropyl-6-methoxypyrimidin-5-yl)-9-(4-(1-methyl-4-(trifluoromethyl)-1H-imidazol-2-yl)benzyl)-7-(2,2,2-trifluoroethyl)-7,9-dihydro-8H-purin-8-imine; CAS: 2839740-79-1 | ||||||
| eNovation CN | 20 days | China To: | 95 | 1 mg | 86.25 | |
| eNovation CN | 20 days | China To: | 95 | 5 mg | 126.50 | |
| eNovation CN | 20 days | China To: | 95 | 10 mg | 178.25 | |
| eNovation CN | 20 days | China To: | 95 | 25 mg | 281.75 | |
| eNovation CN | 20 days | China To: | 95 | 50 mg | 373.75 | |
Description: 2-(4-Cyclopropyl-6-methoxypyrimidin-5-yl)-9-(4-(1-methyl-4-(trifluoromethyl)-1H-imidazol-2-yl)benzyl)-7-(2,2,2-trifluoroethyl)-7,9-dihydro-8H-purin-8-imine; CAS: 2839740-79-1 | ||||||
| 10X CHEM | TBD | United States To: | 98 | 5 mg | 535.70 | |
| 10X CHEM | TBD | United States To: | 98 | 10 mg | 833.80 | |
| 10X CHEM | TBD | United States To: | 98 | 25 mg | 1,640.10 | |
| 10X CHEM | TBD | United States To: | 98 | 50 mg | 2,593.80 | |
| 10X CHEM | TBD | United States To: | 98 | 100 mg | 4,127.20 | |
Description: 2-(4-Cyclopropyl-6-methoxypyrimidin-5-yl)-9-(4-(1-methyl-4-(trifluoromethyl)-1H-imidazol-2-yl)benzyl)-7-(2,2,2-trifluoroethyl)-7,9-dihydro-8H-purin-8-imine; CAS: 2839740-79-1 | ||||||
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire
![Chemical structure of 4-cyclopropyl-6-methoxy-5-[5-methyl-7-({4-[1-methyl-4-(trifluoromethyl)-1H-imidazol-2-yl]phenyl}methyl)-5H-pyrrolo[3,2-d]pyrimidin-2-yl]pyrimidine - CSSB06741706377](/st/structure/200/963826454f8b8a2f157e9f4b3f84c2cc/COc1ncnc%2528C2CC2%2529c1-c1ncc2n%2528C%2529cc%2528Cc3ccc%2528cc3%2529-c3nc%2528cn3C%2529C%2528F%2529%2528F%2529F%2529c2n1.png)
![Chemical structure of 6-(4-cyclopropyl-6-methoxypyrimidin-5-yl)-7-fluoro-3-methyl-1-({4-[1-methyl-4-(trifluoromethyl)-1H-imidazol-2-yl]phenyl}methyl)-1H,2H,3H-imidazo[4,5-c]pyridin-2-one - CSSB17764111963](/st/structure/200/e240f44f2efc3f0afd561dab23987cf9/COC1%253DNC%253DNC%2528C2CC2%2529%253DC1C1%253DNC%253DC2N%2528C%2529C%2528%253DO%2529N%2528CC3%253DCC%253DC%2528C%253DC3%2529C3%253DNC%2528%253DCN3C%2529C%2528F%2529%2528F%2529F%2529C2%253DC1F.png)
![Chemical structure of 4-cyclopropyl-6-methoxy-5-[1-({4-[1-(propan-2-yl)-4-(trifluoromethyl)-1H-imidazol-2-yl]phenyl}methyl)-1H-pyrazolo[3,4-d]pyrimidin-6-yl]pyrimidine - CSSB06454646964](/st/structure/200/580552ae20d9802b4a6b7395a1c8827f/COc1ncnc%2528C2CC2%2529c1-c1ncc2cnn%2528Cc3ccc%2528cc3%2529-c3nc%2528cn3C%2528C%2529C%2529C%2528F%2529%2528F%2529F%2529c2n1.png)
![Chemical structure of 4-cyclopropyl-6-methoxy-5-[7-({4-[1-methyl-4-(trifluoromethyl)-1H-imidazol-2-yl]phenyl}methyl)-5H-pyrrolo[3,2-d]pyrimidin-2-yl]pyrimidine - CSSB14823689089](/st/structure/200/f03e9d6cfb6b613a09a47464d4602a35/COc1ncnc%2528C2CC2%2529c1-c1ncc2%255BnH%255Dcc%2528Cc3ccc%2528cc3%2529-c3nc%2528cn3C%2529C%2528F%2529%2528F%2529F%2529c2n1.png)
![Chemical structure of 9-({4-[1-methyl-4-(trifluoromethyl)-1H-imidazol-2-yl]phenyl}methyl)-2-[2-(propan-2-yl)phenyl]-8,9-dihydro-7H-purin-8-one - CSSB14823689088](/st/structure/200/6eca3064260074fc9a4bb7a57a9b231a/CC%2528C%2529c1ccccc1-c1ncc2%255BnH%255Dc%2528%253DO%2529n%2528Cc3ccc%2528cc3%2529-c3nc%2528cn3C%2529C%2528F%2529%2528F%2529F%2529c2n1.png)
![Chemical structure of 2,5-dihydroxybenzoic acid; 4-cyclopropyl-6-methoxy-5-[1-({4-[1-(propan-2-yl)-4-(trifluoromethyl)-1H-imidazol-2-yl]phenyl}methyl)-1H-pyrazolo[3,4-d]pyrimidin-6-yl]pyrimidine - CSSB20620705639](/st/structure/200/542610059c14f47e664e73fe472f04b0/OC%2528%253DO%2529C1%253DCC%2528O%2529%253DCC%253DC1O.COC1%253DNC%253DNC%2528C2CC2%2529%253DC1C1%253DNC%253DC2C%253DNN%2528CC3%253DCC%253DC%2528C%253DC3%2529C3%253DNC%2528%253DCN3C%2528C%2529C%2529C%2528F%2529%2528F%2529F%2529C2%253DN1.png)
![Chemical structure of 2-[3-fluoro-2-(propan-2-yl)phenyl]-9-({4-[1-methyl-4-(trifluoromethyl)-1H-imidazol-2-yl]phenyl}methyl)-8,9-dihydro-7H-purin-8-one - CSSB06741697637](/st/structure/200/24c9e061263795016a0135153692b1c0/CC%2528C%2529c1c%2528F%2529cccc1-c1ncc2%255BnH%255Dc%2528%253DO%2529n%2528Cc3ccc%2528cc3%2529-c3nc%2528cn3C%2529C%2528F%2529%2528F%2529F%2529c2n1.png)
